Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.29 USD | -3.56% | -16.30% | -45.37% |
May. 23 | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
May. 22 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.37% | 851M | |
+9.91% | 118B | |
+10.19% | 106B | |
-11.64% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.55% | 15.97B | |
+6.45% | 14.03B | |
+14.84% | 11.67B |
- Stock Market
- Equities
- SRRK Stock
- News Scholar Rock Holding Corporation
- Raymond James Initiates Scholar Rock With Strong Buy Rating, $30 Price Target